Why Sintx Technologies Shares Are Trading Lower By 38%; Here Are 20 Stocks Moving Premarket

Author: Lisa Levin | February 08, 2023 08:17am

Gainers

• PainReform Ltd. (NASDAQ:PRFX) shares rose 89.5% to $0.9475 in pre-market trading. PainReform reported receipt of extension to Aug. 7, 2023 to meet the Nasdaq's minimum bid price requirement.
• Aurora Mobile Limited (NASDAQ:JG) rose 34.1% to $1.06 in pre-market trading after the company said it will utilize ChatGPT’s technology to enhance JPush, its push notification solution.
• Youdao, Inc. (NYSE:DAO) rose 22.2% to $8.46 in pre-market trading. Youdao is expected to report Q4 financial results on February 23.
• OceanPal Inc. (NASDAQ:OP) shares rose 15.7% to $1.39 in pre-market trading. OceanPal recently announced time charter contract with Koch Shipping Pte. Ltd., Singapore for m/v Baltimore with Koch.
• SeaStar Medical Holding Corporation (NASDAQ:ICU) shares rose 13.8% to $5.27 in pre-market trading. SeaStar Medical recently submitted investigational device exemption application to the FDA.
• Manchester United plc (NYSE:MANU) rose 13.4% to $23.98 in pre-market trading following a Daily Mail report suggesting Qatari investors could soon make an offer for the company.
• Zhihu Inc. (NYSE:ZH) rose 13.2% to $2.13 in pre-market trading after gaining around 32% on Tuesday.
• Fortinet, Inc.. (NASDAQ:FTNT) rose 11.3% to $60.16 in pre-market trading after the company reported better-than-expected Q4 EPS. The company also issued revenue and EPS guidance with a midpoint above consensus estimates.
• Enphase Energy, Inc. (NASDAQ:ENPH) rose 9.6% to $250.78 in pre-market trading after the company reported better-than-expected Q4 results and issued strong Q1 guidance.
• Magenta Therapeutics, Inc. (NASDAQ:MGTA) rose 9.3% to $0.90 in pre-market trading. Magenta Therapeutics recently announced it will explore strategic alternatives.

Losers

• Sintx Technologies, Inc. (NASDAQ:SINT) fell 37.7% to $3.83 in pre-market trading after the company announced pricing of $12 million public offering of 2.15 million units at a price of $5.60/unit
• Lixte Biotechnology Holdings, Inc. (NASDAQ:LIXT) shares fell 24.6% to $1.42 in pre-market trading. Lixte Biotechnology shares jumped 133% on Tuesday after the company reported on findings from a team of scientists that its LB-100, combined with an inhibitor of the WEE1 kinase, caused effective cancer cell killing.
• SeqLL Inc. (NASDAQ:SQL) shares dropped 17.4% to $1.27 in pre-market trading. SeqLL shares jumped 185% on Tuesday after the company announced the establishment of a two-year Cooperative Research and Development Agreement with the U.S. Department of Justice's Federal Bureau of Investigation.
• Lumen Technologies, Inc. (NASDAQ:LUMN) fell 13.4% to $4.31 in pre-market trading following Q4 results.
• iBio, Inc. (NYSE:IBIO) fell 11.5% to $1.21 in pre-market trading after surging 48% on Tuesday.
• VistaGen Therapeutics, Inc. (NASDAQ:VTGN) fell 9.8% to $0.2350 in pre-market after posting Q3 results.
• Renalytix Plc (NASDAQ:RNLX) fell 8.2% to $2.80 in pre-market trading after gaining around 5% on Tuesday.
• Innovative Eyewear, Inc. (NASDAQ:LUCY) fell 8% to $2.87 in pre-market trading. Innovative Eyewear shares gained 22% on Tuesday after the company announced the launch of its Lucyd Lyte 2.0 audio eyewear line.
• Vaccinex, Inc (NASDAQ:VCNX) shares fell 6.6% to $0.5980 in pre-market trading. Vaccinex shares jumped over 8% on Tuesday after the company was granted U.S. patent #11572408: Treatment Of Cancer With A Semaphorin-4D Antibody In Combination With An Epigenetic Modulating Agent.
• Society Pass Incorporated (NASDAQ:SOPA) fell 6.3% to $1.19 in pre-market trading. Society Pass reported a $2 million buyback program starting Feb. 1.

Now Read This: Fear & Greed Index Moves To 'Extreme Greed' Zone Following Powell Comments

Posted In: DAO ENPH FTNT IBIO ICU JG LIXT LUCY LUMN MANU MGTA OP PRFX RNLX SINT SOPA SQL VCNX VTGN ZH